Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

Abstract Background The development of direct-acting antivirals (DAA) for HCV has revolutionized the treatment of HCV, including its treatment in patients with HIV coinfection. The aim of this study was to compare the changes in liver function between coinfected and monoinfected patients with cirrho...

Full description

Bibliographic Details
Main Authors: Maria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, Franca D’Angelo, Carmine Coppola, Alessia Ciancio, Serena Rita Bruno, Martina Loi, Alessia Giorgini, Marzia Margotti, Valentina Cossiga, Giuseppina Brancaccio, Marcello Dallio, Martina De Siena, Marco Cannizzaro, Luisa Cavalletto, Marco Massari, Maria Mazzitelli, Pasqualina De Leo, Diletta Laccabue, Leonardo Baiocchi, Loreta A. Kondili
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Infectious Diseases
Subjects:
Hepatitis C virus
Human immunodeficiency virus
Real-life cohort
Direct-acting antivirals
Advanced liver disease
Decompensated cirrhosis
Online Access:https://doi.org/10.1186/s12879-021-06053-3

Internet

https://doi.org/10.1186/s12879-021-06053-3

Similar Items